These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8322781)

  • 1. Monitoring diabetic nephropathy: glomerular filtration rate and abnormal albuminuria in diabetic renal disease--reproducibility, progression, and efficacy of antihypertensive intervention.
    Mogensen CE; Hansen KW; Nielsen S; Pedersen MM; Rehling M; Schmitz A
    Am J Kidney Dis; 1993 Jul; 22(1):174-87. PubMed ID: 8322781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-albuminuria and the organ-damage concept in antihypertensive therapy for patients with insulin-dependent diabetes mellitus.
    Mogensen CE; Petersen MM; Hansen KW; Christensen CK
    J Hypertens Suppl; 1992 Apr; 10(1):S43-51. PubMed ID: 1619502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group.
    Jerums G; Allen TJ; Gilbert RE; Hammond J; Cooper ME; Campbell DJ; Raffaele J
    J Diabetes Complications; 1995; 9(4):308-14. PubMed ID: 8573754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria.
    Gambardella S; Frontoni S; Grazia Felici M; Spallone V; Gargiulo P; Morano S; Menzinger G
    Am J Cardiol; 1990 May; 65(17):46H-50H. PubMed ID: 2330907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of beta-blockade and angiotensin converting enzyme inhibition on kidney function in diabetic nephropathy.
    Hommel E
    J Hypertens Suppl; 1989 Sep; 7(7):S49-51. PubMed ID: 2575661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes.
    Mogensen CE
    J Intern Med; 2003 Jul; 254(1):45-66. PubMed ID: 12823642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cilazapril and amlodipine on kidney function in hypertensive NIDDM patients.
    Velussi M; Brocco E; Frigato F; Zolli M; Muollo B; Maioli M; Carraro A; Tonolo G; Fresu P; Cernigoi AM; Fioretto P; Nosadini R
    Diabetes; 1996 Feb; 45(2):216-22. PubMed ID: 8549868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular filtration rate changes in normoalbuminuric and microalbuminuric Type 2 diabetic patients and normal individuals A 10-year follow-up.
    Murussi M; Gross JL; Silveiro SP
    J Diabetes Complications; 2006; 20(4):210-5. PubMed ID: 16798471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of renal disease and hypertension in insulin-dependent diabetes, with an emphasis on early nephropathy.
    Mogensen CE
    Curr Opin Nephrol Hypertens; 1992 Oct; 1(1):106-15. PubMed ID: 1365821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic renal disease: the quest for normotension--and beyond.
    Mogensen CE
    Diabet Med; 1995 Sep; 12(9):756-69. PubMed ID: 8542735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy.
    Parving HH; Smidt UM; Hommel E; Mathiesen ER; Rossing P; Nielsen F; Gall MA
    Am J Kidney Dis; 1993 Jul; 22(1):188-95. PubMed ID: 8322782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
    BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renoprotective action of angiotensin-converting enzyme inhibition in diabetes mellitus.
    Parving HH
    J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S19-24. PubMed ID: 1382160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of incipient nephropathy in type 2 diabetes mellitus.
    Lemley KV; Abdullah I; Myers BD; Meyer TW; Blouch K; Smith WE; Bennett PH; Nelson RG
    Kidney Int; 2000 Sep; 58(3):1228-37. PubMed ID: 10972685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Kidney Int Suppl; 1994 Feb; 45():S145-9. PubMed ID: 8158884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.